Hypogonadism (HG, testicular failure in men) has become a controversial and much misunderstood condition. Many men perceive testosterone as a panacea for the ills of ageing and "Low-T clinics" have sprung up to meet their demands, even though testosterone is often not the answer. In light of the unprecedented rise in testosterone prescriptions in recent years, particularly amongst middle-aged men, the US Food and Drug Administration (FDA) issued a Safety Communication in May 2015 intended to restrict the use of testosterone.
Diagnosing secondary hypogonadism: important consequences for fertility and reversibility / Dean, J; Maggi, M; de Boer, Bj; Hellstrom, W; Khera, M; Kim, Ed; Mccullough, A; Wu, F; Zitzmann, M. - In: BJU INTERNATIONAL. - ISSN 1464-410X. - STAMPA. - 117:(2016), pp. 552-554. [10.1111/bju.13316]
Diagnosing secondary hypogonadism: important consequences for fertility and reversibility.
MAGGI, MARIO;
2016
Abstract
Hypogonadism (HG, testicular failure in men) has become a controversial and much misunderstood condition. Many men perceive testosterone as a panacea for the ills of ageing and "Low-T clinics" have sprung up to meet their demands, even though testosterone is often not the answer. In light of the unprecedented rise in testosterone prescriptions in recent years, particularly amongst middle-aged men, the US Food and Drug Administration (FDA) issued a Safety Communication in May 2015 intended to restrict the use of testosterone.File | Dimensione | Formato | |
---|---|---|---|
Dean_et_al-2016-BJU_International.pdf
Accesso chiuso
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
DRM non definito
Dimensione
151.75 kB
Formato
Adobe PDF
|
151.75 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.